Skip to content

Public FDA record

Z-1305-06: TriActiv ProGuard Embolic Protection System, Part number 61000-01. The product is shipped as a procedure

Recall record Z-1305-06 for Kensey Nash Corp. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1305-06
Company in FDA record
Kensey Nash Corp
FDA classification date
Jul 28, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Alarm activiation-A priming issue involving the flow control unit due to a software problem has caused false postive Extraction Line Block (ELB) alarming. Use of this product may result in a health hazard resulting from early termination of the flush and extraction procedure after stenting

Source facts

Action
The recalling firm issued a draft recall letter to their European distributor who translated the letter for their customers.
Initiated
2006-04-06
Root cause
Other
Terminated
2006-08-10
Distribution
The product was shipped to hospitals in Germany and Italy.
Recall number
Z-1305-06
Recall status
Terminated
CDRH record ID
45714
FDA classified
2006-07-28
Recall event number
35280

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗